1.Background, design, and preliminary implementation of China prospective multicenter birth cohort
Si ZHOU ; Liping GUAN ; Hanbo ZHANG ; Wenzhi YANG ; Qiaoling GENG ; Niya ZHOU ; Wenrui ZHAO ; Jia LI ; Zhiguang ZHAO ; Xi PU ; Dan ZHENG ; Hua JIN ; Fei HOU ; Jie GAO ; Wendi WANG ; Xiaohua WANG ; Aiju LIU ; Luming SUN ; Jing YI ; Zhang MAO ; Zhixu QIU ; Shuzhen WU ; Dongqun HUANG ; Xiaohang CHEN ; Fengxiang WEI ; Lianshuai ZHENG ; Xiao YANG ; Jianguo ZHANG ; Zhongjun LI ; Qingsong LIU ; Leilei WANG ; Lijian ZHAO ; Hongbo QI
Chinese Journal of Perinatal Medicine 2024;27(9):750-755
China prospective multicenter birth cohort (Prospective Omics Health Atlas birth cohort, POHA birth cohort) study was officially launched in 2022. This study, in collaboration with 12 participating units, aims to establish a high-quality, multidimensional cohort comprising 20 000 naturally conceived families and assisted reproductive families. The study involves long-term follow-up of parents and offspring, with corresponding biological samples collected at key time points. Through multi-omics testing and analysis, the study aims to conduct multi-omics big data research across the entire maternal and infant life cycle. The goal is to identify new biomarkers for maternal and infant diseases and provide scientific evidence for risk prediction related to maternal diseases and neonatal health.
2.Traditional Chinese Medicine in Treatment of Ulcerative Colitis Based on NLRP3 Inflammasome: A Review
Yingyi WANG ; Qingsong LIU ; Yi ZHANG ; Shuanglan CHEN ; Xuhui SUN ; Huaie TIAN ; Lingling YUAN
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(15):232-241
Ulcerative colitis (UC) is a common inflammatory bowel disease (IBD) in clinical practice, characterized by symptoms such as abdominal pain, diarrhea, and bloody mucus in the stool. It is difficult to cure and has a high recurrence rate. The pathogenesis of UC is related to abnormal immune response, oxidative stress in intestinal tissues, and inflammatory reactions. As reported, the abnormal activation of the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome is involved in the pathological process of UC. This activation triggers pathological mechanisms such as oxidative stress, pyroptosis, and inflammation in intestinal epithelial cells. Therefore, blocking the abnormal activation of NLRP3 is beneficial for alleviating UC. Currently, western medicine treatment for UC mainly includes salicylic acid derivatives, corticosteroids, and biologics, but the overall efficacy is unsatisfactory. Traditional Chinese medicine (TCM) treatment of this disease has the advantages of significant efficacy and low recurrence rate. In recent years, great advances have been made in the basic research of using TCM methods to treat UC. Studies have found that TCM intervention targeting the NLRP3 inflammasome can significantly promote intestinal mucosal healing and treat UC, and the mechanism of action involves multiple targets, levels, and pathways. This article summarized the experimental research on the impact of TCM targeting the NLRP3 inflammasome on UC in recent years, and found that NLRP3 interacted with factors such as Caspase-1 and nuclear factor-κB (NF-κB), thereby promoting the release of pro-inflammatory factors and cell pyroptosis in intestinal epithelial cells. This activation triggered oxidative stress, inflammatory reactions, and other pathological mechanisms. TCM acted on the NLRP3 inflammasome and its upstream and downstream factors to block the pathological process of UC, inhibit the pathological damage to the intestinal mucosa, and thereby alleviate colonic ulcers. The findings of this study provide a theoretical basis for the prevention and treatment of UC and further drug development.
3.Study on the different extraction fractions of Agrimonia pilosa against hepatic fibrosis
Lin LI ; Chunyan RAO ; Qingsong LEI ; Yi HUANG ; Huabao LIU ; Changjiang ZHANG
China Pharmacy 2022;33(3):313-318
OBJECTIVE To study different extraction fractions of Agrimonia pilosa against h epatic fibrosis. METHODS Using hepatic stellate cells HSC-T 6 of rats as objects ,the effects of different extraction fractions (total extract ,ethyl acetate fraction , petroleum ether fraction and n-butanol fraction )with different concentrations (0.5,5,50,500,5 000 μg/mL,calculated by raw drug)of A. pilosa on the proliferation of HSC-T 6 cells were detected (after treated for 24,48,72 h);median inhibition concentration(IC50)was also caculated. Platelet-derived growth factor (PDGF-BB)was used to induce the activation of HSC-T 6 cells to establish hepatic fibrosis cell model. Flow cytometry was used to detect the effects of different extraction fractions of A. pilosa on apoptosis of HSC-T 6 cells. The expression of collagen Ⅰ(Col-Ⅰ)in the supernatant was detected by enzyme linked immunosorbent assay. The expressions of α-smooth muscle actin (α-SMA),Col-Ⅰ,B-cell lymphoma- 2(Bcl-2),Bcl-2-associated X protein (Bax)and caspase- 3 were detected by Western blot assay. RESULTS Total extract ,ethyl acetate fraction ,petroleum ether fraction and n-butanol fraction of A. pilosa could significantly increase the apoptotic rate of HSC-T 6 cells(P<0.01). After treated for 24 h,IC50 of above fractions were 50.17,20.75,5.82,4.09 μg/mL,respectively. After intervened with PDGF-BB ,the expression of Col- Ⅰ in supernatant of HSC-T 6 cells as well as protein expression of Col- Ⅰ,α-SMA,Bcl-2,Bax and caspase- 3 in HSC-T6 cells were increased significantly (P<0.01). After intervened with different extraction fractions of A. pilosa ,most of the expressions of above proteins in HSC-T 6 cell culture supernatant or cells were significantly reversed compared with PDGF-BB group (P<0.05 or P<0.01), and the intervention effect of n-butanol fraction of A. pilosa was the most significant. CONCLUSIONS Different extraction fractions of A. pilosa can inhibite the proliferation of HSC-T 6 cells and induce their apoptosis;n-butanol fraction from A. pilosa may be an effective fraction to exert the effect of anti-hepatic fibrosis.
4.Study on quality control of mediastinal shift radiotherapy with target volume after operation for non-small cell lung cancer
Wei ZHANG ; Yi ZHANG ; Wei HONG ; Weiwei OUYANG ; Shengfa SU ; Zhu MA ; Qingsong LI ; Wengang YANG ; Xiaxia CHEN ; Jie LIU ; Bing LU
Chinese Journal of Radiation Oncology 2022;31(3):242-247
Objective:To analyze the mediastinal displacement of target volume in the postoperative radiotherapy (PORT) process for non-small cell lung cancer (NSCLC) and the value of mid-term evaluation.Methods:For 100 patients with postoperativeN 2 stage NSCLC, R 1-2 and any N staging, bone anatomy was utilized to measure the change of the first and second CT localization on the same level. Statistical analysis were performed using the WilCoxon, Kruskal-Wallis and χ2 tests. The cut-off values were calculated with the receiver operating characteristic (ROC) curve. Results:Among the included patients, in the PORT process, the mediastinal displacement in the x (front and rear), Y (left and right) and Z (upper and lower) directions were 0.04-0.53 cm, 0.00-0.84 cm and 0.00-1.27 cm, respectively, and the order of mediastinal displacement distance wasz > Y> X,respectively. According to the ROC curve calculation, the cut-off values were 0.263, 0.352 and 0.405, respectively, which were greater than the cut-off values in 25 cases (25%), 30 cases (30%) and 30 cases (30%), respectively. There was significant difference in the three-dimensionalmediastinal displacement ( P=0.007, <0.001 and<0.001). The mediastinal displacement in thex, Y and Z directions had no statistical significance regarding resection site ( P=0.355, 0.239 and 0.256) and operation mode ( P=0.241, 0.110 and 0.064). Comparative analysis of modified whole group mediastinal shift> and cut-off values, medium-simulation (m-S) and the originally planned radiotherapy shown that there was no significant difference in the incidence of radiation esophagitis (RE) and radiation pneumonitis in PORT patients (all P>0.05); however, the incidence of ≥grade 3 RE in the modified plan after m-S was significantly lower than that in the originally planned PORT patients, which were 0 and 7%, respectively ( P<0.001). Conclusions:Mediastinal displacement exists in the PORT process of N 2 or/and R 1-2 cases after radical operation of NSCLC, and obvious movement occurs in 20%-30% of patients. Relocating and modifying the target volume and radiotherapy plan in the middle of the PORT process is beneficial to quality assurance and quality control.
5.Study of volume change and radioherapy timing in patients with stage Ⅳ non-small cell lung cancer by targeted therapy
Xia ZHANG ; Yi ZHANG ; Weiwei OUYANG ; Zhu MA ; Qingsong LI ; Yinxiang HU ; Yichao GENG ; Xiaxia CHEN ; Xiaoyang LI ; Shengfa SU ; Bing LU
Chinese Journal of Radiation Oncology 2020;29(8):633-638
Objective:To investigate the primary tumor volume change and timing of radiotherapy for patients with stage Ⅳ non-small cell lung cancer with EGFR mutation during molecular targeted therapy.Methods:Simulated CT scanning measurement and analysis were performed to observe the volume changes of primary tumors before and after treatment with a time interval of 10 days in this prospective study. Positioning and volume measurement were terminated when the volume change was 5% or less between two time points before and after treatment or 90 days after treatment. Primary tumor radiation therapy was then performed, acute radiation-induced injury was recorded, and the implementation and simulation of related parameters of radiotherapy plans were compared.Results:Twenty-nine of 30 cases were included in the analysis (1 case dropped off). After EGFR-TKIs treatment, the volume of all primary tumors was decreased, but the shrinking rate was inconsistent with the speed. Until the last simulated CT scanning, the maximum and minimum shrinking rates were 90% and 28%, respectively. There was no case of termination within 30 days of treatment, and the average tumor volume was significantly decreased within 40 days and the average tumor volume significantly differed every 10 days ( P<0.001). After 40 days, the volume shrinking rate of primary tumors ≤5% gradually appeared, and one patient presented with a volume shrinking rate of >5% on 90 days. During this time, the average volume shrinking rate slowed down and became stable, ranging from 49.15% to 54.77%. Moreover, the average volume continued to gradually shrink after slight increase at 70 days. There was no significant difference in the average volume every 10 days ( P>0.05). After the termination of simulated CT scanning, the dose of primary tumor was (69±7) Gy for patients receiving radiotherapy. Two patients had grade 2 acute radiation-induced pneumonitis and 3 patients had grade 3 acute radiation-induced pneumonitis. In addition, 1 patient had grade 2 radiation-induced esophagitis. According to the technology and dose parameters of radiotherapy plan, simulated radiotherapy plans before and 40 days after EGFR-TKIs treatment were designed. The timing of implementation plan was significantly better than that before EGFR-TKIs treatment (all P<0.05), whereas it was similar to that at 40 days after EGFR-TKI treatment ( P>0.05). Conclusions:The primary tumor shrinking rate is gradually slowed down over time after EGFR-TKIs treatment in patients with stage Ⅳ non-small cell lung cancer. The average tumor volume is significantly decreased within 40 days and then the shrinking rate becomes slow. The tumor shrinking rate of each case is inconsistent. Radiotherapy at 40 days after treatment is probably the optimal timing to obtain high dose and control radiation-induced injury.
6.Over-expression of miR-144 inhibits invasion of liver cancer SMMC-7721 cells by suppressing TLR/MyD88 pathway.
Qingsong YI ; Jiujiu LIU ; Kurban ALEXIA ; Jing LI ; Hongwu LUO ; Jichun SUN
Journal of Southern Medical University 2020;40(5):765-771
OBJECTIVE:
To investigate the effects of over-expression of miR-144 on invasion of SMMC-7721 cells and Toll-like receptor (TLR)/myeloid differentiation factor 88 (MyD88) pathway in hepatocellular carcinoma cells.
METHODS:
The expressions of miR-144 was examined in normal human hepatocyte line HL-7702 and hepatocarcinoma cell line SMMC-7721 using realtime quantitative PCR (qRT-PCR). SMMC-7721 cells were divided into blank group, miR-144 NC group and miR-144 mimics group, and the expressions of miR-144 in each group were detected with qRT-PCR. Cell count kit-8 (CCK8) was used to assess the survival of SMMC-7721 cells, and the cell invasion was evaluated using Transwell assay. The expressions of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and TLR/MyD88 pathway-related proteins in the cells were detected with Western blotting; the effect of 40 μ mol/L MyD88 inhibitor on TLR/MyD88 pathway-related proteins was examined in SMMC-7721 cells.
RESULTS:
Compared with normal human hepatocytes, SMMC-7721 cells expressed a significantly lower level of miR-144 ( < 0.05). CCK-8 assay showed that test showed that miR-144 over-expression significantly decreased the cell survival rate ( < 0.05), lowered the number of invasive cells, and decreased the expression of MMP-2 and MMP-9 in SMMC-7721 cells ( < 0.05). The expressions of Toll-like receptor 4 (TLR4), MyD88, phosphorylated nuclear factor-kappa B (pNF-κB) and NF-κB protein decreased significantly in miR-144 mimics group and TJ-M2010-2 group ( < 0.05) and were comparable between the two groups ( > 0.05).
CONCLUSIONS
Overexpression of miR-144 decreases SMMC-7721 cell survival and invasion by inhibiting TLR/MyD88 pathway.
Cell Line, Tumor
;
Humans
;
Liver Neoplasms
;
Matrix Metalloproteinase 2
;
MicroRNAs
;
Myeloid Differentiation Factor 88
;
NF-kappa B
;
Signal Transduction
;
Toll-Like Receptors
7. Two different methods of free iliac flap grafting in the repair of tibial defect
Piyu ZHOU ; Shaopu YANG ; Shangquan LI ; Qibo SU ; Yuanjun MA ; Zhenhua HUANG ; Linhu ZHANG ; Liang ZHAO ; Jiang HUANG ; Zhaohua WANG ; Bo LIU ; Qingsong ZHENG ; Qinchao ZHANG ; Yong ZHANG
Chinese Journal of Plastic Surgery 2019;35(12):1230-1233
Objcetive:
To explore the treatment of long segment defect of tibia by using tensor fascia lata combined with iliac flap or deep circumflex iliac pedicle iliac flap.
Methods:
From February 2012 to August 2017, The People′s Hospital of Zun Yi City Bo Zhou District treated 16 patients who had long segment defect of tibia.There were 11 males and 5 females, age from 22 to 58 years old, the average age was 42 years old. Iliac flap grafting with tensor fascia lata combined with iliac flap or deep circumflex iliac pedicle was used to treat the defect of long segment of tibia. There were 4 cases with simple tibial defect and 12 cases with skin defect. The longest tibial defect was 5-8 cm.
Results:
In this study, four patients used iliac flaps with deep circumflex iliac pedicle, the area of flaps ranged from 2.5 cm×5.0 cm to 5.0 cm×10.0 cm, while the area of iliac flaps ranged from 5.0 cm×2.5 cm to 8.0 cm×4.0 cm. Twelve patients used grafting with tensor fascia lata combined with iliac flap, the area of flaps ranged from 5.0 cm×12.0 cm to 12.0 cm×23.0 cm, while the area of iliac flaps ranged from 7.0 cm×2.0 cm to 8.0 cm×4.0 cm. All 16 cases of bone flap were survived, fracture healing, without surgical complications. The average follow-up period was 1.5 years, the flaps had good appearance in 10 cases and was slightly bloated in 6 cases; the ankle had normal motion in 14 cases and had poor dorsal extension in 2 cases. X-ray films showed that the bone flap repaired the bone defects and reached bone healing.
Conclusions
Vascularized tensor fascia lata combined with iliac flap or deep circumflex iliac pedicle iliac flap grafts increase local blood supply and accelerate the process of fracture healing.
8.The effect of active vitamin D on monocyte chemoattratant protein-1 expression from patients with system lupus erythematosus
Xiongyan LUO ; Qin WEI ; Qingsong LIU ; Min YANG ; Minghui YANG ; Lijun WU ; Yi LIU ; Guohua YUAN
Chinese Journal of Rheumatology 2018;22(1):20-23
Objective In order to explore the effect of 25-(OH)D3 on monocyte chemoattratant protein (MCP)-1 expression from patients with system lupus erythematosus (SLE),we detected the level of active vitamin D and the expression of MCP-1 mRNA in patients with SLE,and analyzed the correlation between them.Methods The level of serum 25-(OH)D3 and mRNA expression of MCP-1 in 154 SLE patients and 31 healthy individuals were detected by enzyme-linked immuno sorbent assay (ELISA) and real time quanti-tative pol ymerase chain reaction (PCR) respectively.We also analyzed the correlation between serum 25-(OH)D3 level and the expression of MCP-1 mRNA,then analyzed the function of 25(OH)D3 on the regula-tion of MCP-1 mRNA expression in vitro.The differences between the two groups were tested by t-test and x2 test,multiple data were tested by one-way ANOVA and the correlation was analyzed by Pearson's correlation,all data were analyzed by statistical product and service solutions (SPSS) 17.0 software.Results The serum 25(OH)D3 levels in SLE group (20±11) ng/ml was significantly lower than normal control group (29±11) ng/ml (t=4.198,P<0.01),and the ratio of the serum levels of vitamin D deficiency in SLE group were significantly higher than that of normal control group [55.8%(86/154) vs 22.6%(7/31),x2=11.421,P=0.001].The expression level of MCP-1 mRNA in PBMCs from the normal control group was significantly lower than the SLE group (1.14±0.27 vs 1.44± 0.31,t=3.277,P=0.001),serum 25(OH)D3 level and MCP-1 mRNA expression in patients with SLE PBMCs were significantly negatively correlated (r=-0.289,P<0.01).Further study found that 25-(OH)D3 inhibited MCP-1 mRNA expression in PBMCs from SLE patients depending on the concentration.Conclusion The decreased 25-(OH)D3 level and up-regulated MCP-1 mRNA expression suggestthat MCP-1 may play an important role in SLE pathological process.
9.Detection of autophagy gene expression in T cells from patients with systemic lupus erythematosus
Xiongyan LUO ; Qingsong LIU ; Min YANG ; Minghui YANG ; Yi LIU ; Guohua YUAN
Chinese Journal of Rheumatology 2018;22(6):381-385,后插1
Objective In order to explore the role of autophagy in the development of systemic lupus erythematosus (SLE),we measured the expression of autophagy related gene microtubule-associated protein 1 light chain 3 (LC3),Atg5,Beclinl,Atg7 and the incidence of autophagy in T cells from patients with SLE.Methods The mRNA levels of LC3,Atg5,Beclinl,Atg7 in T cells from 67 SLE patients and 31 healthy individuals were detected by real-time quantitative polymerase chain reacton (qPCR) technique.Autophagy in T cells from 17 SLE patients and 11 healthy controls was also determined by flow cytometry (FACs).The correlation of Atg7 mRNA expression with clincal features was then analyzed.The differences between the two groups were tested by t-test and x2 tcst,all data were analyzed by statistical and service solutions (SPSS) 17.0 software.Results The mRNA levels of LC3 and Atg7 (ΔCT value) in SLE patients were obviously down-regulated as compared to healthy populations (P=0.010,P=0.002),paralleled with the decreased autophagy rate detected by flow cytometry in T cells of SLE patients [(3.7±1.9)% vs (6.6±1.4)%,t=4.132,P=0.000].Also,the protein expression levels of LC3-Ⅱ in T cells of SLE patients (LC3-Ⅱ/GAPDH) was significantly lower than those in healthy controls (0.21±0.08 vs 0.34±0.11,t=1.846,P=0.047).Moreover,Atg7 mRNA expression levels were found to be negatively correlated to autophagy rate (r=-0.492,P=0.008).However,when comparing the clinical features of 24 SLE patients with decreased Atg7 mRNA expression (ΔCT value>9.86) to 43 SLE patients with normal or high Atg7 mRNA expression (ΔCT value <9.86),increasing trend of incidence of arthritis,blood involvement and CNS was noted in patients with decreased Atg7 mRNA expression.However,there was a significant difference between the two groups in the incidence of renal involvement and anti-dsDNA antibody and SLEDAI (P=0.008,P=0.018,P=0.035).Conclusion The impaired autophagy resulted from down-regulated LC3 and Atg7 mRNA levels in T cells from SLE patients indicates that autophagy plays a role in mediating the occurrence and development of SLE,which might be through unable to clean harmful molecules effectively.
10.Clinical application of real-time fluorescence quantitative PCR for the detection of fecal tumor M2-pyruvate kinase in colorectal cancer patients
Yulan LIU ; Fengping HE ; Xin XU ; Qingsong WU ; Dingyun LI ; Zhanzhong MA ; Yanle GUO ; Sheng TANG ; Weidong YIN ; Haitao GONG ; Yi LIU ; Hengxian LIN
International Journal of Laboratory Medicine 2017;38(11):1444-1446
Objective To investigate the application valve of real-time fluorescence quantitative polymerase chain reaction(RT-PCR) for the detection of tumor M2-pyruvate kinase(tM2-PK) DNA in patients with colorectal cancer(CRC).Methods Fragment of tM2-PK DNA(162 bp) was amplified and inserted into PGM-T vector to construct recombinant plasmid,which was used to develop RT-PCR method.Sensitivity,specificity and repeatability of RT-PCR for the detection of tM2-PK were analyzed.From Jan.2014 to Jun.2016,200 CRC patients and 100 healthy subjects were enrolled and detected for fecal and serum tM2-PK DNA by using RT-PCR,and the detected results were compared with those detected by using enzyme linked immunosorbent assay(ELISA).Results Recombinant plasmid was successfully constructed,which was certified by sequencing.The sensitivity of RT-PCR for the detection of tM2-PK DNA was 10 copy/mL,with high specificity and 0.3%-2.9% of coefficient of variation.In patients,the positive rate of fecal tM2-PK DNA,detected by RT-PCR,was 92.50%,and that of ELISA to detect tM2-PK was 80.00%.Fecal and serum levels of tM2-PK were correlated with the pathologic stages of tumour.Conclusion Self-established RT-PCR could be specificity and sensitivity for the detection of fecal tM2-PK,which could be used for the early diagnosis of CRC.

Result Analysis
Print
Save
E-mail